Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting.

Lau AN, Wong-Pack M, Rodjanapiches R, Ioannidis G, Wade S, Spangler L, Balasubramanian A, Pannacciulli N, Lin CJF, Roy-Gayos P, Bensen WG, Bensen R, Adachi JD.

J Rheumatol. 2018 Feb;45(2):170-176. doi: 10.3899/jrheum.161270. Epub 2017 Nov 15.

2.

Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis.

Rahman P, Choquette D, Bensen WG, Khraishi M, Chow A, Zummer M, Shaikh S, Sheriff M, Dixit S, Sholter D, Psaradellis E, Sampalis JS, Letourneau V, Lehman AJ, Nantel F, Rampakakis E, Otawa S, Shawi M.

BMJ Open. 2016 Apr 5;6(4):e009661. doi: 10.1136/bmjopen-2015-009661.

3.

Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study.

Nüßlein HG, Alten R, Galeazzi M, Lorenz HM, Nurmohamed MT, Bensen WG, Burmester GR, Peter HH, Peichl P, Pavelka K, Chartier M, Poncet C, Rauch C, Le Bars M.

Clin Exp Rheumatol. 2016 May-Jun;34(3):489-99. Epub 2016 Mar 10.

PMID:
26966919
4.

Decreased use of glucocorticoids in biological-experienced patients with rheumatoid arthritis who initiated intravenous abatacept: results from the 2-year ACTION study.

Alten R, Nüßlein H, Galeazzi M, Lorenz HM, Nurmohamed MT, Bensen WG, Burmester GR, Peter HH, Pavelka K, Chartier M, Poncet C, Rauch C, Elbez Y, Le Bars M.

RMD Open. 2016 Feb 15;2(1):e000228. doi: 10.1136/rmdopen-2015-000228. eCollection 2016.

5.

The Effects of Noncompliance to Prolia (Denosumab) on the Changes in Bone Mineral Density: A Retrospective Review.

Wong-Pack M, Kalani A, Hordyk J, Ioannidis G, Bensen R, Bensen WG, Papaioannou A, Adachi JD, Lau AN.

J Osteoporos. 2016;2016:7903128. doi: 10.1155/2016/7903128. Epub 2016 Jan 4.

6.

Use of corticosteroids in patients with rheumatoid arthritis treated with infliximab: treatment implications based on a real-world Canadian population.

Haraoui B, Jovaisas A, Bensen WG, Faraawi R, Kelsall J, Dixit S, Rodrigues J, Sheriff M, Rampakakis E, Sampalis JS, Lehman AJ, Otawa S, Nantel F, Shawi M.

RMD Open. 2015 Apr 29;1(1):e000078. doi: 10.1136/rmdopen-2015-000078. eCollection 2015.

7.

Prognostic factors for abatacept retention in patients who received at least one prior biologic agent: an interim analysis from the observational, prospective ACTION study.

Nüßlein HG, Alten R, Galeazzi M, Lorenz HM, Nurmohamed MT, Bensen WG, Burmester GR, Peter HH, Pavelka K, Chartier M, Poncet C, Rauch C, Le Bars M.

BMC Musculoskelet Disord. 2015 Jul 30;16:176. doi: 10.1186/s12891-015-0636-9.

8.

Assessing the Reliability of a Semiautomated Segmentation Algorithm for Quantifying Erosions in the Metacarpophalangeal Joints of Patients with Rheumatoid Arthritis.

Tomizza MA, Jessome MA, Barbosa J, Beattie KA, Bensen WG, Bobba RS, Cividino AA, Emond PD, Gordon C, Hart L, Ioannidis G, Koh MX, Larché M, Tavares R, Tytus S, Adachi JD.

J Rheumatol. 2015 Sep;42(9):1582-6. doi: 10.3899/jrheum.141139. Epub 2015 Jul 15.

PMID:
26178277
9.
10.

Effectiveness and safety of infliximab in rheumatoid arthritis: analysis from a Canadian multicenter prospective observational registry.

Thorne C, Bensen WG, Choquette D, Chow A, Khraishi M, Atkins CJ, Kelsall JT, Lehman AJ, Shawi M, Khalil H, Nantel F, Rampakakis E, Sampalis JS, Otawa S.

Arthritis Care Res (Hoboken). 2014 Aug;66(8):1142-51. doi: 10.1002/acr.22290.

11.

Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study.

Nüßlein HG, Alten R, Galeazzi M, Lorenz HM, Boumpas D, Nurmohamed MT, Bensen WG, Burmester GR, Peter HH, Rainer F, Pavelka K, Chartier M, Poncet C, Rauch C, Bars ML.

BMC Musculoskelet Disord. 2014 Jan 11;15:14. doi: 10.1186/1471-2474-15-14.

12.

Canadian recommendations for clinical trials of pharmacologic interventions in rheumatoid arthritis: inclusion criteria and study design.

Karsh J, Keystone EC, Haraoui B, Thorne JC, Pope JE, Bykerk VP, Maksymowych WP, Zummer M, Bensen WG, Kraishi MM; Canadian Rheumatology Research Consortium.

J Rheumatol. 2011 Oct;38(10):2095-104. doi: 10.3899/jrheum.110188. Epub 2011 Jul 15. Review.

13.

Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study.

Chevalier X, Goupille P, Beaulieu AD, Burch FX, Bensen WG, Conrozier T, Loeuille D, Kivitz AJ, Silver D, Appleton BE.

Arthritis Rheum. 2009 Mar 15;61(3):344-52. doi: 10.1002/art.24096.

14.

Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis.

Díaz-González F, Alten RH, Bensen WG, Brown JP, Sibley JT, Dougados M, Bombardieri S, Durez P, Ortiz P, de-Miquel G, Staab A, Sigmund R, Salin L, Leledy C, Polmar SH.

Ann Rheum Dis. 2007 May;66(5):628-32. Epub 2006 Dec 14.

15.

Upper gastrointestinal tract safety of daily oral risedronate in patients taking NSAIDs: a randomized, double-blind, placebo-controlled trial.

Adami S, Pavelka K, Cline GA, Hosterman MA, Barton IP, Cohen SB, Bensen WG.

Mayo Clin Proc. 2005 Oct;80(10):1278-85.

PMID:
16212139
16.

Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience.

Yocum DE, Furst DE, Bensen WG, Burch FX, Borton MA, Mengle-Gaw LJ, Schwartz BD, Wisememandle W, Mekki QA; Tacrolimus RA Study Group.

Rheumatology (Oxford). 2004 Aug;43(8):992-9. Epub 2004 Mar 10.

PMID:
15014199
17.

Positive effect of etidronate therapy is maintained after drug is terminated in patients using corticosteroids.

Brown JP, Olszynski WP, Hodsman A, Bensen WG, Tenenhouse A, Anastassiades TP, Ste-Marie LG, Kendler DL, Hanley DA, Josse R, Hanly JG, Lentle B, Jovaisas A, Ioannidis G, Stephenson GF, Barton I, Pack S, Chines A, Dias R, Adachi JD.

J Clin Densitom. 2001 Winter;4(4):363-71.

PMID:
11748341
18.

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY; Hip Intervention Program Study Group.

N Engl J Med. 2001 Feb 1;344(5):333-40.

19.
20.

Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.

Bensen WG, Zhao SZ, Burke TA, Zabinski RA, Makuch RW, Maurath CJ, Agrawal NM, Geis GS.

J Rheumatol. 2000 Aug;27(8):1876-83.

PMID:
10955327
21.

Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.

Bensen WG, Fiechtner JJ, McMillen JI, Zhao WW, Yu SS, Woods EM, Hubbard RC, Isakson PC, Verburg KM, Geis GS.

Mayo Clin Proc. 1999 Nov;74(11):1095-105.

PMID:
10560596
22.

36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosis.

Sebaldt RJ, Ioannidis G, Adachi JD, Bensen WG, Bianchi F, Cividino A, Gordon M, Kaminska E, Scocchia T, Petrie A, Stephenson GF, Goldsmith CH.

J Rheumatol. 1999 Jul;26(7):1545-9.

PMID:
10405943
23.

Corticosteroid-induced osteoporosis.

Adachi JD, Bensen WG, Cividino A.

J Am Med Womens Assoc (1972). 1998 Winter;53(1):25-30, 40. Review.

PMID:
9458622
24.

Fluoride therapy in prevention of rheumatoid arthritis induced bone loss.

Adachi JD, Bell MJ, Bensen WG, Bianchi F, Cividino A, Sebaldt RJ, Gordon M, Ioannidis G, Goldsmith C.

J Rheumatol. 1997 Dec;24(12):2308-13.

PMID:
9415633
25.

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.

Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, Kendler DL, Lentle B, Olszynski W, Ste-Marie LG, Tenenhouse A, Chines AA.

N Engl J Med. 1997 Aug 7;337(6):382-7.

26.

Back to the future: the pyramids of rheumatoid arthritis.

Bensen WG, Bensen W, Adachi JD.

J Rheumatol. 1997 Jun;24(6):1023-7.

PMID:
9195503
27.

Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis.

Adachi JD, Bensen WG, Bell MJ, Bianchi FA, Cividino AA, Craig GL, Sturtridge WC, Sebaldt RJ, Steele M, Gordon M, Themeles E, Tugwell P, Roberts R, Gent M.

Br J Rheumatol. 1997 Feb;36(2):255-9.

PMID:
9133941
28.

A double-blind randomised controlled trial of the effects of medroxyprogesterone acetate on bone density of women taking oestrogen replacement therapy.

Adachi JD, Sargeant EJ, Sagle MA, Lamont D, Fawcett PD, Bensen WG, McQueen M, Nazir DJ, Goldsmith CH.

Br J Obstet Gynaecol. 1997 Jan;104(1):64-70.

PMID:
8988699
29.

Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup.

Adachi JD, Bensen WG, Bianchi F, Cividino A, Pillersdorf S, Sebaldt RJ, Tugwell P, Gordon M, Steele M, Webber C, Goldsmith CH.

J Rheumatol. 1996 Jun;23(6):995-1000.

PMID:
8782129
30.

Intermittent cyclic therapy with etidronate prevents corticosteroid-induced bone loss: two years of follow-up.

Sebaldt RJ, Adachi JD, Bensen WG, Bianchi F, Cividano A, Craig GL, Cranney A, Kaminska E, Gordon M, Steele M, Goldsmith C.

Scand J Rheumatol Suppl. 1996;103:91-3.

PMID:
8966498
31.

A multicenter study of nabumetone and diclofenac SR in patients with osteoarthritis.

Bellamy N, Bensen WG, Beaulieu A, Siminovitch KA, Kraag GR, Lussier A, Ahmad S, Khanna VN, Davis P, Bell MJ, et al.

J Rheumatol. 1995 May;22(5):915-20.

PMID:
8587082
32.

Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss.

Adachi J, Cranney A, Goldsmith CH, Bensen WG, Bianchi F, Cividino A, Craig GL, Kaminska E, Sebaldt RJ, Papaioannou A, et al.

J Rheumatol. 1994 Oct;21(10):1922-6.

PMID:
7837160
33.

Corticosteroid-induced osteoporosis.

Adachi JD, Bensen WG, Hodsman AB.

Semin Arthritis Rheum. 1993 Jun;22(6):375-84. Review.

PMID:
8342044
34.
35.

Cyclosporine nephrotoxicity in rheumatoid arthritis: no effect of short term misoprostol treatment.

Boers M, Bensen WG, Ludwin D, Goldsmith CH, Tugwell P.

J Rheumatol. 1992 Apr;19(4):534-7.

PMID:
1593573
36.

The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study.

Long AA, Ginsberg JS, Brill-Edwards P, Johnston M, Turner C, Denburg JA, Bensen WG, Cividino A, Andrew M, Hirsh J.

Thromb Haemost. 1991 Nov 1;66(5):520-4.

PMID:
1803614
38.

Remodelling the pyramid: the therapeutic target of rheumatoid arthritis.

Bensen WG, Bensen W, Adachi JD, Tugwell PX.

J Rheumatol. 1990 Aug;17(8):987-9. No abstract available.

PMID:
2213793
39.

Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis.

Tugwell P, Bombardier C, Gent M, Bennett KJ, Bensen WG, Carette S, Chalmers A, Esdaile JM, Klinkhoff AV, Kraag GR, et al.

Lancet. 1990 May 5;335(8697):1051-5.

PMID:
1970370
40.
41.

Pauciarticular juvenile rheumatoid arthritis presenting in an adult.

Cook DJ, Bensen WG, Shore A, Csordas JE.

J Rheumatol. 1988 Dec;15(12):1865-7.

PMID:
3265962
42.

Giant cell arteritis of the breast.

Cook DJ, Bensen WG, Carroll JJ, Joshi S.

CMAJ. 1988 Sep 15;139(6):513-5. No abstract available.

43.

Late onset gold induced thrombocytopenia.

Cook DJ, Bensen WG, Adachi JD.

J Rheumatol. 1988 Sep;15(9):1450-1. No abstract available.

PMID:
3143835
44.

HLA-DQ polymorphism in rheumatoid arthritis.

Singal DP, Bensen WG, Kassam YB.

Lancet. 1988 Mar 5;1(8584):529. No abstract available.

PMID:
2893937
45.

Low dose cyclosporine in rheumatoid arthritis: a pilot study.

Tugwell P, Bombardier C, Gent M, Bennett K, Ludwin D, Grace E, Buchanan WW, Bensen WG, Bellamy N, Murphy GF, et al.

J Rheumatol. 1987 Dec;14(6):1108-14.

PMID:
3437417
46.

HLA-DQ beta-chain polymorphism in HLA-DR4 haplotypes associated with rheumatoid arthritis.

Singal DP, D'Souza M, Reid B, Bensen WG, Kassam YB, Adachi JD.

Lancet. 1987 Nov 14;2(8568):1118-20.

PMID:
2890022
47.

Gold induced thrombocytopenia: 12 cases and a review of the literature.

Adachi JD, Bensen WG, Kassam Y, Powers PJ, Bianchi FA, Cividino A, Kean WF, Rooney PJ, Craig GL, Buchanan WW, et al.

Semin Arthritis Rheum. 1987 May;16(4):287-93. Review.

PMID:
3110956
48.

An unusual synovial cyst in rheumatoid arthritis.

Martin LF, Bensen WG.

J Rheumatol. 1987 Feb;14(1):139-41. No abstract available.

PMID:
3572916
49.

Gold induced aplastic anemia.

Adachi JD, Bensen WG, Ali M, Singal DP, Taylor S, Whitman L.

J Rheumatol. 1985 Oct;12(5):1011-2. No abstract available.

PMID:
4087250
50.

Is HLA-B27 the ankylosing spondylitis susceptibility gene?

Bensen WG, Singal DP.

J Rheumatol. 1985 Oct;12(5):949-52.

PMID:
3878882

Supplemental Content

Loading ...
Support Center